PLACE LABEL HERE
DELIRIUM
ORDERS
The following orders will be implemented. Orders with a “” are choices and are NOT implemented unless checked.
Initial all handwritten order modifications and the bottom of each page when indicated (multipage).
1.DiagnosisAdmit asInpatient ______(reason for admission)
& Status:Place in Observation ______(reason for observation)
2.Unit: ICU IMCU/PCU Cardiac Telemetry Any Floor Telemetry
3.Consults: Hospitalist for delirium workup
4.ICU-CAM positive per nursing assessment(Only done in ICU/IMCU/PCU)
5. Verify Home Medication Reconciliation form is completed
6.Review current medications with the physician to identify possible pharmacologic causes of delirium
7.If neurological check reveals a focal abnormality or coma, institute stroke alert
8.Place patient on fall precautions
9. Reinforce environmental prevention therapies
10.Diagnostics (IF NOT DONE IN EMERGENCY DEPARTMENT)
Urinalysis and urine culture, Other culture ______
CBC
CMP
Serum levels of: digoxin theophylline antiepileptic drugs ______
Ammonia level
Fingerstick Blood Glucose
EKG NOW
11.Vital signs now and q 4 hrsor Unit Specific
12. Urinary Retention Orders (form #31620), initiate if patient has urinary retention or difficulty voiding
13. Diet: ______
14. Nutrition Supplement Orders (form #31417), initiate if patient meets criteria
15.Activity orders:
OOB to chair q shift
Ambulate q shift
Bedrest
REFERENCE: All require orders
If patient is receiving medications known to cause QT prolongation, Haldol (haloperidol) and Geodon (ziprasidone) are contraindicated. Known to cause QT prolongations: amiodarone, Cipro (ciprofloxacin), Avelox (moxifloxacin), Diflucan (fluconazole), erythromycin, Risperdal (risperidone) and Mellaril (thioridazine, Geodon (ziprasidone) and Haldol (haloperidol).
1.Evaluate all medications, especially medications added over the past 24 - 48 hours
(including drug levels where appropriate)
Anticholinergics
Sedatives / Hypnotics
Analgesics (especially meperidine)
Histamine - 2 receptor antagonists
Digoxin
Antiepileptic drugs
Corticosteroids
Quinolones and other antibiotics
Dopamine
Recently added drugs
2.Complete neurologic exam, including visual field checks
Consider neuroimaging if comatose or new focal abnormality
3.Evaluate for the following
Fluid and electrolyte disturbances
Infection
Drug toxicity
Metabolic disorders
Low perfusion state
Withdrawal from alcohol and sedatives
4.Environmental therapy
Try to keep same staff members with patient
Have family sit with patient
Bring in familiar items
“Busy work” - Baby dolls and folding towels
Identify yourself to patient and give slow, clear, simple, repetitive instructions
Encourage self care and mobility
Discontinue Foley catheter as soon as possible
5.Drug therapy
Avoid benzodiazepines unless withdrawal suspected (alcohol or benzo)
6.Consider EEG if diagnosis obscure or (rarely) LP, if warranted
FORM 4-26785REV. 07/2012 Reference Page Page 1 of 3
PLACE LABEL HERE
DELIRIUM
ORDERS
The following orders will be implemented. Orders with a “” are choices and are NOT implemented unless checked.
Initial all handwritten order modifications and the bottom of each page when indicated (multipage).
MEDICATIONS:
Choose One:
Zyprexa (olanzapine) 5 mg po or per tube now and daily at HS (for patients > 65 yrs)
10 mg po or per tube now and daily at HS
PRN:10 mg IM now and repeat q 2 hrs prn delirium. Max 30 mg/day
Geodon (ziprasidone)20 mg po or per tube BID
PRN:10 mg IM now and repeat q 2 hrs prn delirium. Max 40 mg/day
Baseline QTc and q 24 hrs (daily EKG) while on Geodon (ziprasidone)
If QTc is > 500, DC Geodon (ziprasidone) and notify physician
Critical Care Units ONLY:
Haldol (haloperidol) PRN:
2 mg slow IVP and q 6 hrs prn delirium (for patients >65 yrs). Max 20 mg/day
5 mg slow IVP and q 6 hrs prn delirium. Max 20 mg/day
Baseline QTc and q 24 hrs while on Haldol (haloperidol) therapy
If QTc is > 500, DC Haldol (haloperidol) and notify physician
ADDITIONAL ORDERS:______
______
______
______
______
______
______
______
______
______
DateTimePhysician SignaturePID Number
FORM 4-26785REV. 07/2012 Reference Page Page 1 of 3